Azacitidine in Combination With Low Dose Intensity Venetoclax in Patients With AML Incl. Explorative AML Profiling | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Azacitidine in Combination With Low Dose Intensity Venetoclax in Patients With AML Incl. Explorative AML Profiling	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Recruiting	Phase 2	2022-06-24		NCT05431257

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Copenhagen University Hospital, Rigshospitalet	330
Haukeland University Hospital	163
Helse Møre og Romsdal HF	19
Helse Stavanger HF	67
Helsinki University Central Hospital	127
Karolinska University Hospital	181
Kuopio University Hospital	63
Oulu University Hospital	56
Skane University Hospital	71
St. Olavs Hospital	167
Tampere University Hospital	101
University Hospital of North Norway	93
Uppsala University Hospital	80
Vestre Viken Hospital Trust	60

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Department of Hematology, Rigshospitalet	Copenhagen	Denmark	1